• One Health
  • Pain Management
  • Oncology
  • Geriatric & Palliative Medicine
  • Ophthalmology
  • Anatomic Pathology
  • Poultry Medicine
  • Infectious Diseases
  • Dermatology
  • Theriogenology
  • Nutrition
  • Animal Welfare
  • Radiology
  • Internal Medicine
  • Small Ruminant
  • Cardiology
  • Dentistry
  • Feline Medicine
  • Soft Tissue Surgery
  • Urology/Nephrology
  • Avian & Exotic
  • Preventive Medicine
  • Anesthesiology & Pain Management
  • Integrative & Holistic Medicine
  • Food Animals
  • Behavior
  • Zoo Medicine
  • Toxicology
  • Orthopedics
  • Emergency & Critical Care
  • Equine Medicine
  • Pharmacology
  • Pediatrics
  • Respiratory Medicine
  • Shelter Medicine
  • Parasitology
  • Clinical Pathology
  • Virtual Care
  • Rehabilitation
  • Epidemiology
  • Fish Medicine
  • Diabetes
  • Livestock
  • Endocrinology

Pet Releaf debuts professional product line with Sentesa

Publication
Article
dvm360dvm360 August 2021
Volume 52

Hemp-based capsules that promote patient health and healing are the first product of Pet Releaf’s Professional Line for veterinarians.

Image courtesy of Pet Releaf

Image courtesy of Pet Releaf

Pet Releaf, the market-leading hemp health brand for pets, has released Sentesa, a hemp-based supplement featuring a triactive formula. Sentesa was developed by veterinarians, exclusively for veterinarians and specially made to help manage canines’ inflammatory response, calmness, joint flexibility and mobility, and discomfort, according to a company release. Proved safe and fast acting to guarantee efficacy, Sentesa’s triactive formula consists of cannabidiol (CBD), β-caryophyllene, and caprylic acid.

"We knew from our veterinary partners that there is an unmet need for data-driven product development in the hemp space. We focused on delivering products to the veterinarian that can safely and effectively manage their patients’ longterm health and well-being,” says Alina Smith, CEO and cofounder of Pet Releaf, in this release. “We are proud to offer Sentesa as a safe, effective, and natural alternative to help bridge a needed gap in pet care.”

Made with the highest-quality ingredients and manufactured in a cGMP (Current Good Manufacturing Practice) facility, Sentesa has undergone testing in a third-party accredited laboratory and evaluation in clinical studies.

“It can be difficult to treat pets through chronic diseases and long-term pain. Incorporating Sentesa into veterinary practices can help pets suffering from a multitude of ailments in a more all-natural way, without the harmful adverse effects that may be caused by pharmaceuticals,” says Joseph Rosentel, DVM, PhD, MS, vice president of product development and supply chain, in the release. “With the data-driven approach to development, completed safety and PK study, and an ongoing field safety and efficacy study, we are thrilled to offer the veterinarian a new option for the treatment of their patients.”

The capsules are available in 2 sizes: for small dogs (11-33 pounds) and medium/ large dogs (33+ pounds). Sentesa for small dogs contains 10 mg of CBD, 10 mg of β-caryophyllene, and 10 mg of caprylic acid. Sentesa for medium/large dogs contains 30 mg of CBD, 30 mg of β-caryophyllene, and 30 mg of caprylic acid

Related Videos
Senior Bernese Mountain dog
© 2023 MJH Life Sciences

All rights reserved.